The invention relates to novel compounds of the formula (I) which can be used for the inhibition of serine-threonine protein kinases and for the sensitisation of cancer cells to anticancer agents and/or ionising radiation.

This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules, and processes of using such molecules against such pests. These molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses molecules having the following formula (Formula One and Formula Two). ##STR00001##

This disclosure relates to the field of molecules having pesticidal utility against pests in phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules, and processes of using such molecules against such pests. These molecules may be used, for example, as nematicides, acaricides, insecticides, miticides, and/or molluscicides. This document discloses molecules having the following formula (Formula One and Formula Two). ##STR00001##

The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.

The present invention provides new compounds and compositions thereof that release carbon monoxide for the treatment of medical disorders that are responsive to carbon monoxide, for example, inflammatory, pain, and dermatological disorders.

An additive for a non-aqueous electrolyte solution including a compound represented by the following formula (A1) or (A2).

##STR00001##

In the formula, X.sup.a represents a group that forms a cyclic group together with a nitrogen atom, Z.sup.a1 and Z.sup.a2, Z.sup.a1 and Z.sup.a2 each independently represent a sulfonyl or carbonyl group, R.sup.a1 represents an optionally substituted alkylene group of 1 to 4 carbon atoms, an alkenylene group of 3 or 4 carbon atoms or an alkynylene group of 3 or 4 carbon atoms, R.sup.a2 represents a hydrogen atom, a halogen atom or an optionally substituted alkyl group of 1 to 4 carbon atoms, R.sup.a3 represents oxygen or an optionally substituted alkylene group of 1 to 4 carbon atoms, alkenylene group of 3 or 4 carbon atoms or alkynylene group of 3 or 4 carbon atoms.

An additive for a non-aqueous electrolyte solution including a compound represented by the following formula (A1) or (A2).

##STR00001##

In the formula, X.sup.a represents a group that forms a cyclic group together with a nitrogen atom, Z.sup.a1 and Z.sup.a2, Z.sup.a1 and Z.sup.a2 each independently represent a sulfonyl or carbonyl group, R.sup.a1 represents an optionally substituted alkylene group of 1 to 4 carbon atoms, an alkenylene group of 3 or 4 carbon atoms or an alkynylene group of 3 or 4 carbon atoms, R.sup.a2 represents a hydrogen atom, a halogen atom or an optionally substituted alkyl group of 1 to 4 carbon atoms, R.sup.a3 represents oxygen or an optionally substituted alkylene group of 1 to 4 carbon atoms, alkenylene group of 3 or 4 carbon atoms or alkynylene group of 3 or 4 carbon atoms.

A resist composition which generates acid upon exposure and exhibits changed solubility in a developing solution under action of acid, the resist composition including a base component which exhibits changed solubility in a developing solution under action of acid, and a compound represented by general formula (d1) in which R.sup.d01 and R.sup.d02 each independently represents a cyclic group which may have a substituent, a chain alkyl group which may have a substituent or a chain alkenyl group which may have a substituent; or R.sup.d01 and R.sup.d02 may be mutually bonded to form a condensed ring; m represents an integer of 1 or more; and M.sup.m+ represents an organic cation having a valency of m.

##STR00001##

A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium catalyst followed by oxidation of the olefinic bond to provide 3-heterocyclyl-1,2-dihydroxy cyclohexanes, cyclopentanes and corresponding alicyclic heterocycles. Also disclosed are methods for converting the heterocyclyl-1,2-dihydroxy cyclohexanes to 2-amino-6-(heteroaryl)cyclohexanols (and related cyclic compounds).

A process for the stereoselective synthesis of chiral 3-heterocyclyl-1,2-dihydroxy cyclohexanes is disclosed. The process involves reacting a tricyclic nitrogenous heterocycle with an allyl carbonate in the presence of a chiral palladium catalyst followed by oxidation of the olefinic bond to provide 3-heterocyclyl-1,2-dihydroxy cyclohexanes, cyclopentanes and corresponding alicyclic heterocycles. Also disclosed are methods for converting the heterocyclyl-1,2-dihydroxy cyclohexanes to 2-amino-6-(heteroaryl)cyclohexanols (and related cyclic compounds).